Zacks: Brokerages Expect U.S. Physical Therapy, Inc. (NYSE:USPH) Will Post Quarterly Sales of $123.07 Million

Equities research analysts expect U.S. Physical Therapy, Inc. (NYSE:USPH) to announce sales of $123.07 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for U.S. Physical Therapy’s earnings, with the highest sales estimate coming in at $125.10 million and the lowest estimate coming in at $119.13 million. U.S. Physical Therapy posted sales of $83.86 million in the same quarter last year, which suggests a positive year over year growth rate of 46.8%. The company is expected to announce its next earnings report before the market opens on Thursday, August 5th.

According to Zacks, analysts expect that U.S. Physical Therapy will report full year sales of $482.35 million for the current financial year, with estimates ranging from $470.25 million to $488.40 million. For the next year, analysts expect that the company will post sales of $511.03 million, with estimates ranging from $501.94 million to $519.60 million. Zacks’ sales calculations are an average based on a survey of analysts that that provide coverage for U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.17. U.S. Physical Therapy had a return on equity of 14.19% and a net margin of 7.73%. The company had revenue of $112.37 million during the quarter, compared to the consensus estimate of $110.36 million. During the same quarter in the prior year, the firm posted $0.30 earnings per share. The firm’s revenue was down .3% compared to the same quarter last year.

Several research analysts have recently issued reports on the company. Zacks Investment Research raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 13th. Jefferies Financial Group raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and increased their target price for the company from $130.00 to $135.00 in a research report on Monday, May 3rd. Finally, Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 target price for the company in a research report on Friday, May 7th.

Shares of U.S. Physical Therapy stock traded down $1.87 on Friday, hitting $110.80. The stock had a trading volume of 176 shares, compared to its average volume of 53,687. The company has a 50 day moving average of $116.55. U.S. Physical Therapy has a twelve month low of $74.79 and a twelve month high of $143.67. The company has a quick ratio of 0.83, a current ratio of 0.83 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $1.43 billion, a price-to-earnings ratio of 38.17 and a beta of 1.46.

The company also recently announced a quarterly dividend, which was paid on Friday, June 11th. Shareholders of record on Friday, May 14th were given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date was Thursday, May 13th. U.S. Physical Therapy’s dividend payout ratio is presently 46.82%.

In other news, Director Mark J. Brookner sold 1,250 shares of the firm’s stock in a transaction that occurred on Wednesday, June 2nd. The shares were sold at an average price of $120.00, for a total transaction of $150,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mark J. Brookner sold 1,000 shares of the stock in a transaction on Tuesday, May 11th. The stock was sold at an average price of $120.25, for a total value of $120,250.00. Following the completion of the transaction, the director now owns 14,600 shares in the company, valued at $1,755,650. The disclosure for this sale can be found here. Insiders have sold a total of 5,069 shares of company stock valued at $604,874 in the last three months. Insiders own 1.80% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Ensign Peak Advisors Inc lifted its stake in U.S. Physical Therapy by 2.5% during the 1st quarter. Ensign Peak Advisors Inc now owns 95,931 shares of the company’s stock valued at $9,987,000 after acquiring an additional 2,347 shares in the last quarter. Wasatch Advisors Inc. lifted its stake in U.S. Physical Therapy by 51.3% during the 1st quarter. Wasatch Advisors Inc. now owns 258,037 shares of the company’s stock valued at $26,862,000 after acquiring an additional 87,462 shares in the last quarter. Engineers Gate Manager LP bought a new position in U.S. Physical Therapy during the 4th quarter valued at $889,000. Cresset Asset Management LLC bought a new position in U.S. Physical Therapy during the 1st quarter valued at $220,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in U.S. Physical Therapy during the 1st quarter valued at $911,000. Institutional investors own 97.69% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: New Google Finance Tool and Screening Stocks

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.